<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-MGEJRZVO</identifier><date>2011</date><creator>Knez, Lea</creator><relation>documents/doc/M/URN_NBN_SI_doc-MGEJRZVO_001.htm</relation><relation>documents/doc/M/URN_NBN_SI_doc-MGEJRZVO_001.pdf</relation><relation>documents/doc/M/URN_NBN_SI_doc-MGEJRZVO_001.txt</relation><format format_type="issue">5</format><format format_type="volume">62</format><format format_type="type">article</format><format format_type="extent">str. 259-260</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">29463513</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-MGEJRZVO</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">bolniki</subject><subject language_type_id="slv">farmacevti</subject><subject language_type_id="slv">klinična farmacija</subject><subject language_type_id="slv">onkologija</subject><title>Vloga farmacevta pri zagotavljanju varnosti onkoloških bolnikov med sistemskim zdravljenjem raka</title></Record>